Regulation of dendritic cell recruitment into resting and inflamed airway epithelium: use of alternative chemokine receptors as a function of inducing stimulus.
Dendritic cells (DC) were purified by flow cytometry from rat tracheal mucosa; they exhibited the phenotypic characteristics of immature DC including high endocytic activity, low CD80/86 expression, and in vitro responsiveness to a broad range of CC chemokines. Daily treatment of adult rats with the selective CCR1 and CCR5 antagonist Met-RANTES reduced baseline numbers of tracheal intraepithelial DC by 50-60%, and pretreatment of animals with Met-RANTES before inhalation of aerosol containing heat-killed bacteria abolished the rapid DC influx into the epithelium that occurred in untreated controls, implicating CCR1 and CCR5 and their ligands in recruitment of immature DC precursors into resting airway tissues and during acute bacterial-induced inflammation. Comparable levels of DC recruitment were observed during airway mucosal Sendai virus infection and after aerosol challenge of sensitized animals with the soluble recall Ag OVA. However, Met-RANTES did not affect these latter responses, indicating the use of alternative chemokine receptors/ligands for DC recruitment, or possibly attraction of different DC subsets, depending on the nature of the eliciting stimulus.
Stumbles
P A
PA
TVW Telethon Institute for Child Health Research, and Centre for Child Health Research, University of Western Australia, Perth, Western Australia, Australia.
Strickland
D H
DH
Pimm
C L
CL
Proksch
S F
SF
Marsh
A M
AM
McWilliam
A S
AS
Bosco
A
A
Tobagus
I
I
Thomas
J A
JA
Napoli
S
S
Proudfoot
A E
AE
Wells
T N
TN
Holt
P G
PG
D000280:Administration, Inhalation; D000281:Administration, Intranasal; D000336:Aerosols; D000818:Animals; D002465:Cell Movement / Q000276:immunology*; D002469:Cell Separation; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D004847:Epithelial Cells / Q000166:cytology / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D007249:Inflammation / Q000276:immunology / Q000382:microbiology / Q000821:virology; D007274:Injections, Intraperitoneal; D007399:Interphase / Q000276:immunology*; D001936:Moraxella catarrhalis / Q000276:immunology; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology; D051381:Rats; D011919:Rats, Inbred Strains; D019707:Receptors, Chemokine / Q000096:biosynthesis / Q000502:physiology*; D020545:Respiratory Mucosa / Q000166:cytology / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D018108:Respirovirus / Q000276:immunology; D012995:Solubility; D013997:Time Factors; D014132:Trachea / Q000166:cytology / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*
D000336:Aerosols; D019707:Receptors, Chemokine; D010047:Ovalbumin